Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature-Reference-Cited by-同舟云学术

Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature

Published:2015-02 Issue: Volume:200 Page:106-114
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Araki Tomoya,Ogawara Ken-ichi,Suzuki Haruka,Kawai Rie,Watanabe Taka-ichi,Ono Tsutomu,Higaki Kazutaka^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors;Drummond;Pharmacol. Rev.,1999

2. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles;Ernsting;J. Control. Release,2013

3. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect;Fang;Adv. Drug Deliv. Rev.,2011

4. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy;Yoshizawa;Int. J. Pharm.,2011

5. Pharmacokinetics of pegylated liposomal doxorubicin review of animal and human studies;Gabizon;Clin. Pharmacokinet.,2003

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionalizing tetrahedral framework nucleic acids-based nanostructures for tumor in situ imaging and treatment;Colloids and Surfaces B: Biointerfaces;2024-08

2. Engineering photodynamics for treatment, priming and imaging;Nature Reviews Bioengineering;2024-06-19

3. Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling;Cancer and Metastasis Reviews;2022-09-26

4. Sequential administration of PEG-Span 80 niosome enhances anti-tumor effect of doxorubicin-containing PEG liposome;European Journal of Pharmaceutics and Biopharmaceutics;2021-12

5. MoS2-based nanocomposites for cancer diagnosis and therapy;Bioactive Materials;2021-11